eli lilly and tirzepatide sues companies selling alternative versions of its weight loss drug Eli Lilly Adds Highest Doses

Case presentation We describe a 40-year-old man with metabolic syndrome and obesity who had been treated with semaglutide for several years before discontinuation

Recent small studies have shown undetectable levels of semaglutide in breast milk, leading many experts to believe it is also likely safe, though caution is still advised

Any use of Rybelsus for weight loss in non-diabetic individuals would be "off-label" and must be carefully managed by a doctor, considering the cost and side effects

Both drugs were part of a class of appetite suppressants called serotonergic anorectics, which work by lowering the amount of serotonin in the brain